REFERENCES
- Fu K., Pack D., Lavadiere A., Son S., Langer R. Visualization of pH in degrading polymer microspheres. Proc. Int. Symp. Controlled Release Bioactive Mater 1998; 25: 150–151
- Rosilio V., Deyme M., Benoit J. P., Madelmont G. Physical aging of progesterone-loaded poly(D,L-lactide-co-glycolide) microspheres. Pharm. Res. 1998; 15: 794–798
- Chang A. C., Gupta R. K. Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen. J. Pharm. Sci. 1996; 85: 129–132
- Cleland J., Mac A., Boyd B., Yang J., Duenas E. T., Yeung D., Brooks B., Hsu C., Chu H., Makku V., Jones J. S. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm. Res. 1997; 14: 420–425
- Shenderova A., Burke T., Schwendeman S. P. Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles. Pharm. Res. 1997; 14: 1406–1414
- Johnson O. L., Jaworowicz W., Cleland J. L., Bailey L., Charnis M., Duenas E., Wu C., Shepard D., Magil S., Last T., Jones A. J. S., Putney S. D. The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm. Res. 1997; 14: 730–735
- Brunner A., Mader K., Gopferich A. The chemical microenvironment inside biodegradable microspheres during erosion. Proc. Int. Symp. Controlled Release Bioactive Mater 1998; 25: 154–155
- Uchida T., Yagi A., Oda Y., Nakada Y., Goto S. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. Chem. Pharm. Bull. 1996; 44: 235–236
- Hande K. R. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur. J. Cancer 1998; 34: 1514–1521
- Slevin M. The clinical pharmacology of etoposide. Cancer 1991; 67: 31–39
- O'Dwyer P., Leyland-Jones B., Alonso M. T., Marsoni S., Wittes R. E. Etoposide: current status of an active anticancer. drug. N. Engl. J. Med. 1985; 312: 692–698
- Wolf S. N., Grosh W. W., Prater K., Hande K. R. In vitro pharmacodynamic evaluation of VP-16213 and implications for chemotherapy. Cancer Chemother. Pharmacol. 1987; 19: 246–249
- Lewis D. D. Controlled release of bioactive agents from lactide/glycolide polymers. Biodegradable Polymers as Drug Delivery Systems, M. Chasin, R. Langer. Marcel Dekker, New York 1990; 1–41
- Jain R., Navnit H. S., Mallick A. W., Rhodes C. T. Controlled delivery by biodegradable poly(ester) devices: different preparative approaches. Drug Dev. Ind. Pharm. 1998; 24: 703–727
- Sato H., Wang Y. M., Adachi I., Horikoshi I. Pharmacokinetic study of taxol-loaded poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate after targeted delivery to the lung in mice. Biol. Pharm. Bull. 1996; 19: 1596–1601
- Wang Y. W., Sato H., Adachi I., Horikoshi I. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol. Chem. Pharm. Bull. 1996; 44: 1935–1940
- Juni K., Ogata J., Matsui N., Kubota M., Nakano M. Modification of the release rate of aclarabicin from polylactic acid microspheres. Chem. Pharm. Bull. 1985; 33: 1734–1738
- Chow D., Shah J. Stability-indicating high performance liquid chromatography of etoposide at various pH conditions using a reversed-phase octyl column. J. Chromatogr. 1987; 396: 217–223
- Joost J. M., Holthius E. M., van den Bosch J. J., Bult A. Analytical Profiles of Drug Substances, K. Florey. Academic Press, San Diego, CA 1989; 19: 345–349